Takeda Pharmaceutical will eliminate nearly 1,600 jobs in the U.S., mostly in sales, as part of a plan to save more than $500 million over three years. "This will position us for success in 2010 and beyond so we can continue the important work of research and development in order to deliver important new treatments for unmet patient needs," the Japanese drugmaker said.

Related Summaries